Report Description

Global Dental Bone Graft Substitute Market stood at USD735.48 million in 2021 and is further anticipated to grow at a CAGR of 7.00%, during the forecast period owing to rising geriatric population. Additionally, growing popularity of medical and dental tourism especially in the developing countries especially in the Asia Pacific region is expected to create lucrative opportunities for the market growth in the coming years. Due to the low cost of dental treatment and the availability of surgeons, the number of overseas patients seeking these operations is expected to increase.

Furthermore, increased focus of key players on research and development in bone grafts and substitutes, as well as an increase in demand for orthopedic operations among the geriatric population, are projected to provide market players with lucrative prospects in the future.

Rising Inclination towards Cosmetic Dentistry

Customer’s growing desire for dental bone graft substitutes, as well as a growing preference for cosmetic dentistry, are two important growth drivers for the industry. Major global population is unhappy with the appearance of their teeth. The growing number of cosmetic dental surgeries across the globe has significantly increased the demand for dental bone graft substitutes.

Increase in Geriatric Population

The expanding target population is a major factor in the market for dental bone transplants and alternatives. According to the Population Division of the Department of Economic and Social Affairs, the global share of individuals aged 60 and more increased from 9.2% in 1990 to 11.7 percent in 2013 and is anticipated to rise to 21.1 percent by 2050. The demand for dental grafting is increasing due to an increased frequency of periodontal disease, root caries, and edentulous patients, as well as the senior population.

Increase in Dental Tourism

Patients now have a better alternative to bone transplants thanks to advances in Dental bone graft substitutes, but their expensive cost has hindered its use among price-conscious customers. In this product category, developed regions such as North America and Europe have a strong presence of innovative product makers. However, the costs of products as well as the expenses of procedures in hospitals in these regions are greater than in growing nations such as India, China, and Brazil, which may prove to be the key driving force for market expansion.


DOWNLOAD FREE SAMPLE REPORT

Market Segmentation

The Global Dental Bone Graft Substitute Market is segmented based on Type, Material, Mechanism, Product Type, Application, End User, and Region’s distribution. Based on type of Material, the market can be split into Allograft, Xenograft, Autograft, Synthetic Bone Graft, Others. Based on Material, the market can be divided into Human Cell Source, Collagen, Animal Source, Others, Others. Based on Mechanism, the market is divided into Osteoconduction, Osteoinduction, Osteopromotion, Osteogenesis. Based on Product type, the market is divided into Bio OSS, Grafton and Osteograf. In terms of Application, the market can be categorized into Socket Preservation, Ridge Augmentation, Periodontal Defect Regeneration, Implant Bone Regeneration, Sinus Lift. Based on End User, the market is split into Hospitals & Clinics, Dental Laboratories, Others. Regionally, North America dominated the market in 2021 among Europe, Asia Pacific, South America and Middle East & Africa region. United States is the biggest market for dental bone graft substitutes and stood at USD207.54 million in 2021 on account of widespread use and adoption of dental bone graft substitutes in various restorative and cosmetic surgeries.

Company Profiles

Institut Straumann AG, Medtronic Plc., Zimmer Biomet Holdings, Inc., Envista Holdings Corporation (Danaher Corporation), DENTSPLY Sirona, Inc., Johnson & Johnson, Stryker Corporation, Halma Plc. (NovaBone), Geistlich Pharma AG, RTI Surgical, are among the major market players in the global platform that lead the market growth of the global Dental Bone Graft Substitute market.

Attribute

Details

Market size value in 2021

USD 735.48 Million

Revenue Forecast in 2027

USD 1096.34 Million

United States Market size value in 2021

 

USD 207.54 Million

Growth Rate

7.00%

Base Year

2021

Historical Years

2017 – 2027

Estimated Year

2022

Forecast Period

2021 – 2027

Quantitative Units

Revenue in USD Million, and CAGR for 2017-2021 and 2022-2027

Report Coverage

Revenue forecast, company share, competitive landscape, growth factors, and trends

Segments Covered

·         Type

·         Material

·         Mechanism

·         Product

·         Application

·         End User

Regional Scope

North America; Europe; Asia Pacific; South America; Middle East & Africa

Country Scope

United States; Canada; Mexico; Germany; Italy; France; Poland; Spain; United Kingdom; China; India; Japan; South Korea; Thailand; Australia; Malaysia; Vietnam; Brazil; Argentina; Colombia; Turkey; Egypt; Saudi Arabia; UAE; South Africa

Key Companies Profiled

Institut Straumann AG, Medtronic Plc., Zimmer Biomet Holdings, Inc., Envista Holdings Corporation (Danaher Corporation), DENTSPLY Sirona, Inc., Johnson & Johnson, Stryker Corporation, Halma Plc.(NovaBone), Geistlich Pharma AG, RTI Surgical.

Customization Scope

10% free report customization with purchase. Addition or alteration to country, regional & segment scope.

Pricing and Purchase Options

Avail customized purchase options to meet your exact research needs. Explore purchase options

Delivery Format

PDF and Excel through Email (We can also provide the editable version of the report in PPT/pdf format on special request)

 

Report Scope: